 |
|
Overview of aristolochic acid nephropathy: an update
Qingqing Zhou, Lei Jiang, Tao Su, Gang Liu, Li Yang
Kidney Res Clin Pract. 2023;42(5):579-590. Published online 2023 Jun 15 DOI: https://doi.org/10.23876/j.krcp.22.211
|
|
Citations to this article as recorded by
 Quantum Dot-Based Immunoassays: Unraveling Sensitivity Discrepancies and Charting Future Frontiers
Mei Dang, Longjiang Wu, Gelin Jin, Chenxuan Yang, Murtala Bindawa Isah, Xiaoying Zhang
Analytical Chemistry.2024; 96(3): 980. CrossRef Changes in the Expression of C-Myc and Cyclin D1 in Mice with Acute Aristolochic Acid Nephropathy
爱琳 兰
Advances in Clinical Medicine.2024; 14(04): 1749. CrossRef Identification and analysis of differently expressed transcription factors in aristolochic acid nephropathy
Yi-Feng Wu, Zhi-Yao Tang, Yi-Xuan Deng, Kun Liu, Xu-Rui Gu, Guang-Liang Zhou, Yu-Jie Huang, Xiao-Qing Lin, Lin-Yun Zhou, Xiao-Cong Zuo
Environmental Health and Preventive Medicine.2024; 29: 30. CrossRef Establishment of enzyme-linked immunosorbent assay for aristolochic acid
Ning Lu, Xiaolu Wang, Yu Wang, Yue Du, Qianni Gao, Huimin Zhang
Toxicon.2024; 244: 107771. CrossRef Gut tumors in flies alter the taste valence of an anti-tumorigenic bitter compound
Nicole Y. Leung, Chiwei Xu, Joshua Shing Shun Li, Anindya Ganguly, Geoff T. Meyerhof, Yannik Regimbald-Dumas, Elizabeth A. Lane, David T. Breault, Xi He, Norbert Perrimon, Craig Montell
Current Biology.2024; 34(12): 2623. CrossRef A case of Fanconi syndrome that developed following a year of consumption of a red yeast rice supplement
Yuki Kawai, Moe Ozawa, Aya Isomura, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Shohei Nagayama, Shohei Tanaka, Eriko Abe, Sanae Saka, Kiyotaka Nagahama, Tamio Iwamoto, Kouichi Tamura
CEN Case Reports.2024;[Epub] CrossRef Mitochondrial Dysfunction in Aristolochic Acid I-Induced Kidney Diseases: What We Know and What We Do Not Know
Alexandra T. Lukinich-Gruia, Crenguta L. Calma, Flavia A. E. Szekely, Iustina-Mirabela Cristea, Maria-Alexandra Pricop, Alina-Georgiana Simina, Valentin L. Ordodi, Nikola M. Pavlović, Calin A. Tatu, Virgil Paunescu
Applied Sciences.2024; 14(17): 7961. CrossRef New insight into oxidative stress and inflammatory responses to kidney stones: Potential therapeutic strategies with natural active ingredients
Yue Sun, Hongmei Sun, Zhengze Zhang, Futing Tan, Yunxia Qu, Xiaojing Lei, Qingzhu Xu, Jiangtao Wang, Lindan Shu, Huai Xiao, Zhibin Yang, Heng Liu
Biomedicine & Pharmacotherapy.2024; 179: 117333. CrossRef Disruption of local circadian clocks in aristolochic acid-induced nephropathy in mice
Dihao Xie, Simin Zhong, Meixue Luo, Jiahao Xu, Ruoyan Zheng, Jiading Luo, Yiting Wang, Yongxing Guo, Lianxia Guo, Baojian Wu, Danyi Lu
Phytomedicine.2024; 135: 156235. CrossRef Aristolochic acid I promotes renal tubulointerstitial fibrosis by up-regulating expression of indoleamine 2,3-dioxygenase-1 (IDO1)
Langqun Chen, Siyu Cheng, Jiahui Ying, Qi Zhang, Chen Wang, Huimin Wu, Ying Wang, Hong Zhang, Jiahe Wang, Jing Ye, Liang Zhang
Toxicology Letters.2024; 402: 44. CrossRef
|